Results 21 to 30 of about 670,718 (407)

Complexed Prostate-specific Antigen and the “Prostate-specific Antigen Gap” [PDF]

Clinical Chemistry, 1999
Jung et al. (1) reported an apparent gap between total serum prostate-specific antigen (t-PSA) and the sum of free PSA (f-PSA) plus α1-antichymotrypsin-PSA (ACT-PSA) in patients with prostate carcinoma (PCa) but not in those with benign prostatic hypertrophy (BPH).
Bernard L. Croal, Ian Mitchell, Patrica A. Duff, A. Dickie, Nicholas P. Cohen, I Ross   +5 more
openaire   +2 more sources

The role of antigen-competitive dynamics in regulating the immune response [PDF]

Bulletin of Mathematical Biology, 83(5): 40 (2021), 2021
The clonal expansion of T cells during an infection is tightly regulated to ensure an appropriate immune response against invading pathogens. Although experiments have mapped the trajectory from expansion to contraction, the interplay between mechanisms that control this response are not fully understood.
arxiv   +1 more source

Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis

British medical journal, 2018
Objective To investigate the efficacy and safety of prostate-specific antigen (PSA) testing to screen for prostate cancer. Design Systematic review and meta-analysis.
D. Ilić, Mia Djulbegovic, J. Jung, E. Hwang, Qi Zhou, A. Cleves, T. Agoritsas, P. Dahm   +7 more
semanticscholar   +1 more source

Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy [PDF]

, 2022
Background Prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT) is increasingly incorporated in the therapeutic algorithm of patients with metastatic castration-resistant prostate cancer (mCRPC).
Buck, Andreas K., Bundschuh, Ralph A., Essler, Markus, Hartrampf, Philipp E., Kübler, Hubert, Seitz, Anna Katharina, Weinzierl, Franz‐Xaver, Werner, Rudolf A.   +7 more
core   +1 more source

The diagnostic value of a new formula combining age and prostate volume in prostate cancer

Journal of Men's Health, 2022
Background and objective: This study combined two clinical indicators (age and prostate volume (PV)) to generate age to PV (AVR) ratio, whose diagnostic value for prostate cancer (PCa) was examined based on prostate specific antigen (PSA) in the range
Xiaobo Yang, Jiahao Shan, Qiang Zhang, Zhongyu Yuan, Haoran Xu, Ziyang Liu, Xiaojie Zhou, Wenzhuo Ma, Hongbin Shi   +8 more
doaj   +1 more source

Oral ethinylestradiol in castration resistent prostate cancer: 10 year experience [PDF]

, 2015
To describe our 10-year experience with the use of oral ethinylestradiol in the treatment of metastatic castration-resistant prostate cancer. METHODS: From February 2000 to April 2010, 116 patients with a metastatic castration-resistant prostate cancer
Aggarwal, Beer, Bonkhoff, Bono, Chadha, Corey, Di Silverio, Gasent Blesa, Izumi, Kitahara, Limonta, Montgomery, Shamash, Stein, Takezawa, Tannock, Wilkins   +16 more
core   +1 more source

Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: A nested case-control study [PDF]

, 2014
Vitamin D pathway single nucleotide polymorphisms (SNPs) are potentially useful proxies for investigating whether circulating vitamin D metabolites [total 25-hydroxyvitamin-D, 25(OH)D; 1,25-dihydroxyvitamin, 1,25(OH)2D] are causally related to prostate ...
Bonilla, Carolina, Donovan, Jenny L., Evans, David M., Fraser, William D., Gilbert, Rebecca, Hamdy, Freddie C., Kemp, John P., Lane, J. Athene, Lathrop, Mark, Lewis, Sarah, Martin, Richard M., Metcalfe, Chris, Neal, David E., Smith, George Davey   +13 more
core   +3 more sources

Biomarkers for prostate cancer: prostate-specific antigen and beyond

Clinical Chemistry and Laboratory Medicine, 2019
In recent years, several new biomarkers supplementing the role of prostate-specific antigen (PSA) have become available for men with prostate cancer. Although widely used in an ad hoc manner, the role of PSA in screening asymptomatic men for prostate ...
M. Duffy
semanticscholar   +1 more source

Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in Asia

Asian Journal of Andrology, 2015
In Western countries, clinical trials on prostate cancer screening demonstrated a limited benefit for patient survival. In the Asia-Pacific region, including Japan, the rate of prostate-specific antigen (PSA) testing remains very low compared with ...
Yasuhide Kitagawa, Mikio Namiki
doaj   +1 more source

Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer

Clinical Cancer Research, 2019
Purpose: Systemic androgen-signaling inhibition added to ongoing androgen-deprivation therapy (ADT) improved clinical outcomes in patients with nonmetastatic castration-resistant prostate cancer without detectable metastases by conventional imaging ...
W. Fendler, Manuel Weber, A. Iravani, M. Hofman, J. Calais, J. Czernin, H. Ilhan, F. Saad, E. Small, Matthew R. Smith, P. M. Perez, T. Hope, I. Rauscher, A. Londhe, A. Lopez-Gitlitz, Shinta Cheng, T. Maurer, K. Herrmann, M. Eiber, B. Hadaschik   +19 more
semanticscholar   +1 more source